Christian Bioethics is a pivotal journal published by Oxford University Press, dedicated to the interdisciplinary exploration of bioethical issues from a Christian perspective. Since its inception in 1995, the journal has served as a crucial platform for scholars, practitioners, and students to engage with complex ethical questions at the intersection of medicine, philosophy, and religious studies. With an evolving scope that reflects contemporary debates in bioethics, the journal has achieved notable rankings, including Q2 in Religious Studies and Q3 in Philosophy in 2023, underscoring its significance in these fields. While not open access, Christian Bioethics continues to bridge gaps between faith and science, encouraging rigorous dialogue on how Christian ethics can inform bioethical decision-making and policy. It is essential reading for those looking to deepen their understanding of ethical issues shaped by religious convictions, making it an invaluable resource for researchers and professionals alike.

Ethics & Bioethics is a vital interdisciplinary journal published by DE GRUYTER POLAND SP Z O O, focusing on the ethical dimensions of biological and medical practices. Since its transition to an Open Access model in 2016, the journal has become more accessible, promoting the dissemination of high-quality research to a broader audience. Based in Warsaw, Poland, this journal contributes significantly to the discourse on ethical practices in health policy, education, and philosophy, as evidenced by its impressive Scopus rankings, including a Q1 quartile in Philosophy. Covering a wide spectrum of ethical issues and dilemmas faced in contemporary society, Ethics & Bioethics provides a platform for researchers, professionals, and students to engage with cutting-edge scholarship aimed at advancing understanding and fostering dialogue in the ever-evolving landscape of bioethics. With a commitment to rigorous peer review and academic integrity, this journal is pivotal for those seeking to enhance their knowledge and contribute to the field.

Linacre Quarterly, published by SAGE Publications Inc, is a distinguished journal that serves as an interdisciplinary platform in the fields of Health Policy and Philosophy. With an ISSN of 0024-3639 and an E-ISSN of 2050-8549, this journal has been pivotal in providing insights into the intricate dynamics of health policy through a philosophical lens since its inception in 1945. Notably, it holds a respectable 2023 Scopus rank, placing it in the 68th percentile within the Arts and Humanities (Philosophy) category and the 21st percentile in Medicine (Health Policy). Though currently not offering Open Access options, Linacre Quarterly remains committed to advancing scholarly discussion and fostering innovation among researchers, professionals, and students alike. Located in the United Kingdom, this journal continues to uphold its reputation as a vital resource for those navigating the complexities of health-related ethical dilemmas and policy-making frameworks, thereby enhancing its visibility and relevance in academic discourse.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

Medecine & Droit, an esteemed journal published by ELSEVIER MASSON, CORP OFF, serves as a vital resource for the intersection of law and medicine. Since its inception in 1995, this journal has facilitated scholarly discourse by publishing innovative research, case studies, and reviews that explore the complexities of legal frameworks impacting medical practice and public health. Although currently classified in the fourth quartile within both the Law and Medicine (miscellaneous) categories for 2023, its contributions are important for legal professionals and healthcare providers seeking to navigate the evolving landscape of medical laws. With an ISSN of 1246-7391 and E-ISSN 1873-6475, it provides essential insights and stimulates interdisciplinary collaboration within academia. Authors and researchers are encouraged to contribute and engage with critical topics shaping the future of medicine and law through this essential publication.

The KENNEDY INSTITUTE OF ETHICS JOURNAL, published by the prestigious Johns Hopkins University Press, stands as a leading periodical in the realm of ethics, particularly emphasizing the intersection of health policy, social sciences, history, and philosophy of science. With an ISSN of 1054-6863 and an E-ISSN of 1086-3249, this journal has been a cornerstone of ethical discourse since its inception in 1991. Renowned for its rigorous peer-review process, the journal boasts impressive rankings, including Q1 in History and Philosophy of Science and Q2 in Health (Social Science) for 2023. Researchers, professionals, and students alike will find this journal invaluable for navigating complex ethical issues, providing a platform for innovative research and discourse. Although currently not offering Open Access, its contributions to the fields of ethics and legal aspects of health are profound, making it an essential resource for those engaged in these critical discussions.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

HEC Forum, an esteemed journal published by Springer, is dedicated to advancing the field of health policy and ethics, bridging critical gaps between healthcare practices and legal frameworks. With the ISSN 0956-2737 and the E-ISSN 1572-8498, this journal has been a pivotal platform since its inception in 1989, collaborating with scholars and practitioners up to the year 2024. Recognized within the Q3 quartile of several categories—including Health Policy and Issues, Ethics and Legal Aspects—HEC Forum holds a significant position in scholarly circles, showcasing rigorous research and discussions relevant to today’s health care challenges. The journal's Scopus rankings highlight its impact, positioned favorably in the realms of Nursing and Health Policy. Although it does not offer open access, HEC Forum remains a critical resource for researchers, professionals, and students seeking to deepen their understanding of health ethics and policy implications in a rapidly evolving landscape.